Oramed Pharmaceuticals (ORMP +1%) gains after receiving approval for a key patent by the...

|About: Oramed Pharmaceuticals Inc. (ORMP)|By:, SA News Editor

Oramed Pharmaceuticals (ORMP +1%) gains after receiving approval for a key patent by the Japanese Patent Office. The patent, which has also been approved in Israel and Australia, is titled "Methods and Compositions for Oral Administrations of Proteins," and covers a core concept of the company's technology. ORMP's portfolio now consists of seven issued patents with 28 patents pending.